Acumen Pharmaceuticals
IPOPublic · Charlottesville, United States · Founded 2016 · $35.8M raised
- Headquarters
- Charlottesville, Virginia
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- acumenpharm.com
- Total Funding
- $35.8M
- Last Round
- $35.8M Private EquityMar 2026
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Clinical-stage biopharmaceutical company developing targeted therapies for Alzheimer's disease focused on toxic amyloid beta oligomers.
Summary
Acumen Pharmaceuticals is a Biotech company based in Charlottesville, United States, founded in 2016. It has raised $35.8M in total across 1 round, most recently a $35.8M Private Equity round in Mar 2026. Investors include RA Capital Management, ADAR1 Capital and Sands Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Mar 2026
Sign up to see all 3 events
Funding: Private Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/acumen-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/acumen-pharmaceuticals" alt="Acumen Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>